Apr 20, 2020
ImpediMed Releases Most Comprehensive Software Package for SOZO® Digital Health Platform
Apr 15, 2020
Los Angeles County Cancer Center Embraces the Future of Cancer Care by Installing Four ImpediMed SOZO® Devices
Mar 02, 2020
$4.2 Billion Compression Therapy Industry (2019 to 2025) - Growth Potential Offered By Emerging Markets Presents Opportunities
Mar 02, 2020
$4.2 Billion Compression Therapy Industry (2019 to 2025) - Growth Potential Offered By Emerging Markets Presents Opportunities
Mar 02, 2020
$4.2 Billion Compression Therapy Industry (2019 to 2025) - Growth Potential Offered By Emerging Markets Presents Opportunities
Feb 21, 2020
Compression Therapy Market Worth $4.2 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Nov 05, 2019
The global lymphedema diagnostics market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%
Nov 05, 2019
Global Lymphedema Diagnostics Market Report 2019: Lymphoscintigraphy is Rapidly Developing to Be the First-Line Imaging Modality for Lymphedema Diagnostics
Oct 25, 2019
Lymphedema Diagnostics Market Worth $35 Million by 2024 - Exclusive Market Report by M&M
Oct 23, 2019
ImpediMed Announces Ambitious New Program Aimed at Ending Cancer-Related Lymphedema
Sep 28, 2019
PRMA Plastic Surgery Celebrates 25 Years of Providing Advanced Breast Reconstruction
Jul 12, 2019
More Than Skin Deep: Understanding the Dangers of Cellulitis
Nov 01, 2018
WebMD Announces Health Heroes
Oct 16, 2018
Eiger BioPharmaceuticals Announces Phase 2 ULTRA Results of Ubenimex in Lower Leg Lymphedema: Study Did Not Meet Primary or Secondary Endpoint
Oct 02, 2018
PRMA Expands, Providing Lymphedema Surgery and Breast Reconstruction Options to Corpus Christi, Texas
Sep 05, 2018
medi USA introduces the new ready-to-wear circaid® juxtafit® essentials armsleeve
Jun 13, 2018
Autologous Lymph Node Transfer: New Hope for Combating Lymphedema
Feb 13, 2018
MediPoint: Pneumatic Compression Therapy - Global Analysis and Market Forecasts
Jan 16, 2018
Eiger BioPharmaceuticals Announces Phase 2 LIBERTY Study in Pulmonary Arterial Hypertension Did Not Meet Primary Endpoint
Jan 04, 2018
Eiger BioPharmaceuticals Completes Enrollment of Phase 2 ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients